IFP Advisors, Inc - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2022$479
-99.9%
10,050
+0.5%
0.01%
+8.3%
Q3 2022$477,000
+23750.0%
10,000
+2757.1%
0.01%
Q2 2021$2,0000.0%3500.0%0.00%
Q1 2021$2,0003500.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$1,000
-75.0%
190
-24.0%
0.00%
Q4 2018$4,000
-85.2%
250
-37.5%
0.00%
-100.0%
Q1 2018$27,0000.0%4000.0%0.00%0.0%
Q4 2017$27,000
-73.8%
400
-68.0%
0.00%
-75.0%
Q3 2017$103,000
-22.0%
1,250
-11.0%
0.00%
-33.3%
Q2 2017$132,000
-33.3%
1,405
-54.8%
0.01%
-33.3%
Q1 2017$198,000
+9.4%
3,110
-23.7%
0.01%0.0%
Q4 2016$181,000
-42.2%
4,075
-53.0%
0.01%
-43.8%
Q3 2016$313,000
+281.7%
8,675
+44.6%
0.02%
+220.0%
Q2 2016$82,000
+86.4%
6,000
+380.0%
0.01%
+66.7%
Q4 2015$44,0001,2500.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders